NY-WELCH-ALLYN
Welch Allyn , a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, today announced it has partnered with seca , global leader in medical measuring and weighing systems, to enable wireless automated interface between the Welch Allyn Connex® Vital Signs Monitor (VSM) and seca scales and measuring devices with the seca 360° system. The partnership allows Welch Allyn to offer for the first time a wirelessly connected weight and height patient data solution for both physician and hospital customers in low-acuity settings.
The two devices communicate wirelessly through a seca adapter that plugs into the Welch Allyn Connex VSM. They can be up to 98 feet apart, depending upon office configuration, and still communicate, which will help increase workflow by reducing the need to move equipment from room to room. Automating the interface between the respective devices can also help eliminate documentation errors by reducing the need for manual parameter recording, while also increasing the speed of recording weight and height into electronic medical records (EMR).
“In order to improve patient outcomes, healthcare providers need access to accurate patient data from the initial point of care,” said Doug Linquest, senior vice president, Vital Signs Business Unit at Welch Allyn. “And the availability of wireless connectivity between a Welch Allyn vital signs monitor and seca 360° devices allows us to provide a solution that will add up-to-date patient weight and height directly to their data and then can be transferred to an EMR.”
Under the agreement, seca scales and measuring devices with the seca 360° system include digital column scales, measuring stations, pediatric scales, multifunctional wheelchair scales, bariatric scales, chair scales and seca’s newest device – the seca mBCA (medical Body Composition Analyzer). Each device is designed to accommodate every kind of patient need quickly and accurately in a physician or hospital setting.
“Doctor visits in any setting tend to start with the measurement of vital signs—blood pressure, temperature, and, of course, weight and height—all essential information to provide proper care and treatment to the patient,” said Lyndsey Nunez, marketing manager of seca North America. “This partnership seems to be a natural fit between seca and Welch Allyn as both companies focus on providing solutions that help improve the first interaction between healthcare providers and patients. Additionally, the seca 360° system encrypts the transmission by Advanced Encryption Standard (AES) with seca’s own wireless protocol, and is protected from interaction with other networks. So, multiple seca devices can be used together, and with the Welch Allyn Connex VSM, securely in any clinical environment. We look forward to the benefits this creates for healthcare professionals around the world who are looking to utilize reliable technology in their everyday practice.”
The seca 360° wireless scales and measuring devices are available in countries where the Welch Allyn Connex VSM is sold. For more information, visit www.welchallyn.com or www.seca.com .
About Welch Allyn
Welch Allyn helps reduce risk and improve patient safety, satisfaction and outcomes in a variety of clinical settings through a complete range of EMR-interfaced vital signs and cardiac monitoring diagnostic solutions, physical diagnosis instruments and infection control products. The company specializes in helping doctors, nurses and other frontline providers across the globe streamline workflow by developing innovative solutions that enable immediate access to accurate patient data. A leading global healthcare company founded in 1915 and headquartered in Skaneateles Falls, N.Y. (USA), Welch Allyn is a family-owned business that employs nearly 2,600 employees in 26 different countries. More information about Welch Allyn and its complete line of connected products and solutions may be found at www.welchallyn.com . Like us on Facebook and follow us on Twitter .
About seca
seca, the global leader in medical measuring and weighing, offers healthcare providers advanced wireless technology and system solutions that go beyond height and weight. Based on 170 years of quality German engineering, seca medical devices set the standard for innovation, design and reliability. On every continent, doctors and nurses in medical practices, hospitals and nursing homes rely on the high quality of seca’s medical scales and measuring systems. seca products range from pediatric scales and measuring systems, measuring stations and column scales, flat scales, height measuring systems, multifunctional and wheelchair scales, chair scales, body composition analyzers and other specialized scales. To learn more about seca products visit www.seca.com .
Contact:
Welch Allyn
Jamie Arnold, APR
Public Relations
Manager
1-315-685-4599
jamie.arnold@welchallyn.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
New Study from UK’s Largest Virtual ADHD Service Validates Role of Objective Testing in Delivering Personalized, High-Quality Remote ADHD Care10.5.2025 12:45:00 CEST | Press release
Data presented at ADHD World Congress highlights how QbCheck supports diagnostic accuracy and individualized treatment monitoring, enabling efficient and robust care in virtual settings. News Summary: New findings show significant improvements in access, clinician confidence, symptom tracking, and individualized care using objective testing. The study underscores the importance of scalable, evidence-based tools, as many countries, including both the UK and the US, face rising demand for ADHD diagnosis and treatment. The study revealed significant improvements post-treatment, validating clinical practice and better clinician-patient alignment. As demand for virtual ADHD care increases, findings from a new study conducted with ADHD 360, the UK’s largest evidence-based digital service specializing in ADHD diagnosis and treatment, reveal how objective ADHD diagnostic and monitoring technology improves patient outcomes and clinical certainty. Presented at the 2025 ADHD World Congress in Pra
Ant International Partners with Barclays on Global Treasury Management with Proprietary AI-Powered FX Model9.5.2025 15:57:00 CEST | Press release
The Time-Series Transformer AI FX Model forecasts cashflow and FX exposure with more than 90% accuracy, helping businesses reduce FX-related fees Ant International has entered a partnership with leading UK bank Barclays to enhance efficiency and resilience in global treasury management for businesses. Under the partnership, the two sides will combine innovative solutions, including Ant’s proprietary Time-Series Transformer (TST) AI FX Model, to help businesses reduce FX-related costs and risks against global volatilities. At the initial stage of the collaboration, Ant International has successfully completed the first batch of its intra-group FX transactions with Barclays. Ant International’s TST Model is a transformer architecture-based big data model with close to 2 billion parameters. By integrating the latest time series forecasting algorithms, the TST Model predicts patterns over time. Ant also created new pre-training and Supervised Fine-Tuning (SFT) frameworks to train the model
IFF Completes Divestiture of Nitrocellulose Business9.5.2025 14:00:00 CEST | Press release
IFF (NYSE: IFF) today announced that it has completed the divestiture of its nitrocellulose business, including Walsrode Industrial Park in lower Saxony, Germany, to Czechoslovak Group (CSG). The business manufactures nitrocellulose strictly for industrial purposes, serving customers primarily in coatings and printing inks, and had been part of IFF’s Pharma Solutions business unit. “The divestiture of our nitrocellulose business builds upon our deleveraging journey and enables us to focus on our core businesses,” said Erik Fyrwald, IFF CEO. “I’d like to thank our nitrocellulose colleagues for their dedication and wish them continued success as part of CSG.” Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience.Le
Monument Re Transfers €1.4bn Greycastle Portfolio to RGA and Strengthens European Life Insurance Consolidation Platform9.5.2025 14:00:00 CEST | Press release
Monument Re Limited (“Monument”) announces today that it has transferred a legacy €1.4bn reinsurance portfolio, comprising annuity and other life insurance liabilities acquired as part of the 2020 Greycastle transaction, to RGA Americas Reinsurance Company, Ltd. (“RGA”). This transaction releases capital resources that Monument will redirect to its core strategy of consolidation in European life insurance markets. The transaction completed on 2May 2025 following approval by the Boards of Directors of both Monument and RGA and non-objection from the Bermuda Monetary Authority. Monument has taken significant steps in recent months to strengthen its business operations by consolidating its European group support functions in Dublin and by aligning with the recently strengthened regulatory regime in Bermuda. With its strong financial position and best in class capabilities in the Group, Monument remains ideally positioned to build on its success to date and grow its European footprint, del
CPAC Systems AB Announces Strategic Minority Investment in Flying Fish9.5.2025 12:33:00 CEST | Press release
Accelerating the shift toward sustainable and intelligent water mobility CPAC Systems AB, a leader in advanced control systems and embedded vessel and commercial vehicle technology, today announced a strategic minority investment in Flying Fish Maritime Innovations B.V., a pioneer in advanced shared water mobility solutions and robust, cost-effective hydrofoil technology. The investment underscores both companies’ commitment to redefining water-based transportation through innovation, sustainability, and seamless integration. It marks the beginning of a deeper collaboration aimed at enabling smarter, cleaner, and more connected mobility on the water — for both recreational and commercial applications. “We are thrilled to support Flying Fish and their impressive work in redefining water mobility,"saidMarcus Wingolf, CEO of CPAC Systems. "Our investment in Flying Fish represents a strategic alignment of our technical proficiencies and innovative ambitions. This partnership opens exciting
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum